Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Entero Therapeutics ( (ENTO) ) is now available.
Entero Therapeutics has appointed Jason D. Sawyer as the Interim Chief Executive Officer, effective September 4, 2025. The company has entered into a consulting agreement with Mr. Sawyer, providing him with a monthly compensation of $12,500 and indemnification under Delaware General Corporation Law, reflecting a strategic move in its leadership structure.
More about Entero Therapeutics
Average Trading Volume: 1,887,863
Technical Sentiment Signal: Sell
Current Market Cap: $3.65M
See more data about ENTO stock on TipRanks’ Stock Analysis page.